Oxalosis and Hyperoxaluria Foundation (OHF) - Home



We Are The OHF
The OHF is made up of a resourceful staff, a committed Board of Directors and an esteemed Scientific Advisory Board of top experts from around the globe. In addition, volunteers from all walks of life give generously of their time and talents to help the OHF make a difference.

Office Staff
Board of Directors
National Advisory Board
Scientific Advisory Board Members
Scientific Advisory Council
Patient Advisory Board

Office Staff
The efforts of the OHF are coordinated by a professional staff and is headquartered in New York, New York.

Kim Hollander, Executive Director
New York, New York
kimh@ohf.org, (800) OHF-8699 x 1 or (800) 643-8699 x 1

Julie Bertarelli, Mid-West Coordinator
St. Louis, Missouri
julieb@ohf.org, (800) OHF -8699 x 2 or (800) 643-8699 x 2

OHF Board Of Directors
Our voluntary Board of Directors oversees the OHF. The Board is comprised of parents, doctors, researchers and business people from across the country.

Officers

Brett Rosen, President
New York, New York
CPA, Senior Managing Director, Cowan Financial Group, LLC


Tim Berra, Vice President
St. Louis, Missouri
President, Heidtman Steel


Debra Wattenberg, MD, Vice President of Scientific and Medical Affairs
New York, New York
Dermatology Practice


Donald L. Ashkenase, Treasurer
Great Neck, New York
Executive Vice President - Corporate
Montefiore Medical Center


Lisa Berra, Secretary
St. Louis, Missouri


Members

Bernd Hoppe, MD
University Children's Hospital
Kinderdialyse
Josef-Stelzman Str. 9
D-50924 Cologne, Germany

Craig B. Langman, MD, Medical Editor
Chicago, Illinois
Isaac A. Abt, MD Professor of Kidney Diseases
Feinberg School of Medicine, Northwestern University
Head, Kidney Diseases, Childrens Memorial Medical Center

Alexey L. Margolin, PhD
Cambridge, MA

Brendan McGovern
Managing Director, Portfolio Manager
Goldman, Sachs & Co.

OHF National Advisory Board

Donny Deutsch
New York, New York
President, Deutsch, Inc.

Craig and Caryn Effron
New York, New York

Harvey M. Schwartz
New York, New York
Managing Director, Partner
Goldman Sachs

Allen M. Spiegel, MD
Bronx, New York
Dean, Albert Einstein College of Medicine

Scientific Advisory Board
The Scientific Advisory Board (SAB) provides advice, as well as medical and scientific expertise to the OHF on an ongoing basis. The SAB is regularly informed of the progress of OHF research and development projects and provides feedback and ideas intended to accelerate the development process. The SAB also fulfills the role of external advisors involved in project-specific reviews and enhances the OHF's innovation process by providing support to the OHF scientific and medical community. Members of the SAB volunteer their time, individual knowledge and expertise to help broaden the scope, content, health and balance of related issues.


Chris Danpure, BSc, PhD, Chairperson
Department of Biology
University College London
Gower Street
London, WC1E6B United Kingdom
[bio]
 
Dean G. Assimos, MD
Professor of Surgical Sciences
Department of Urology
Wake Forest University School of Medicine
[bio]
 
Marguerite Hatch, PhD
The University of Florida
Department of Pathology
College of Medicine, Box 100275
Gainesville, Florida 32610-0275
[bio]
 
Markus J. Kemper, MD
Pediatric Nephrology
University Medical Center Hamburg-Eppendorf
Martinistr. 52; D-20246
Hamburg, Germany
[bio]
 
John C. Lieske, MD
Department of Pediatric Nephrology
Mayo Clinic
200 First Street
Rochester, Minnesota, 55005
[bio]
 

Dawn Milliner, MD
Mayo Clinic
200 First Street
Rochester, Minnesota 55005
[bio]
 
Jayanta Roy-Chowdhury, MD
Professor of Medicine and Molecular Genetics
Albert Einstein College of Medicine
1300 Morris Ave
Bronx,New York 10461
[bio]
 
Gill Rumsby, PhD, FRC, Path
Consultant Biochemist
Clinical Biochemistry UCL Hospitals
[bio]
 
Eduardo Salido, MD, PhD
Hospital Universitario 1
FRC Investigacion
Ofra, Tenerife, E-38320
[bio]
 
Chandra Tucker, PhD
University of Colorado Medical School
12801 E 17th Street, L18-6113
Aurora, Colorado 80045
[bio]
 

Scientific Advisory Council
The Scientific Advisory Council (SAC), comprised of specialists and experts in related fields, provides independent advice as needed to the Scientific Advisory Board (SAB) on matters of concern in the fields of Oxalosis, PH and related stone diseases. The SAC may also review the Foundation's research portfolio and identify promising new areas of research.


John Asplin, MD
University of Chicago
Section of Nephrology
MC5100
5841 S. Maryland Avenue
Chicago, Illinois 60637
 
Pierre Cochat, MD
Département de Pédiatrie & Inserm U499
Hôpital Edouard-Herriot & Université Claude-Bernard
 
Scott Cramer, PhD
Associate Professor
Department of Cancer Biology
Wake Forest University School of Medicine
 
John Herrin, MD
Division of Nephrology
Children's Hospital Hun 3
 
Ross Holmes, PhD
Department of Urology
Wake Forest School of Medicine
Medical Center Boulevard
Winston-Salem, NC 27157
 
Julie A. Jonassen, PhD
Associate Professor
University of Massachusetts Medical School
Department of Physiology
 
Saeed Khan, PhD
Department of Pathology
1600 SW Archer Road
P.O. Box 100275
Gainesville, Florida 32610-0275
 

Hari K Koul, MSc, PhD, FACN
Professor and Director of Research,
Department of Surgery-Division of Urology
School of Medicine,
University of Colorado Health Sciences Center
 
Kay Latta, MD
Clementine-Kinderhospital
 
Robert B. Miller, MD
Albuquerque, New Mexico
 
Carla Monico, MD
Division of Nephrology
Mayo Clinic
 
Helen O'Connor, MS, RD, CCRP
General Clinic Research Center
Mayo Clinic College of Medicine
 
Craig Peters, MD
Department of Urology
Children's Hospital Boston
Harvard Medical School
 
Edward Purdue, PhD
Department of Biology
Mount Sinai School of Medicine
 
William Robertson, PhD
Institute of Urology/Nephrology
University College London
 
Jon Scheinman, MD
Chief, Pediatric Nephrology Section
University of Kansas
 
 

Patient Advisory Board
The Patient Advisory Board (PAB) is the newest member to the OHF Family. The PAB is comprised of patients, parents, family members, caregivers and is facilitated by members of the OHF staff. The role of the PAB is to support OHF's mission by providing valuable input to expand research, education, programs and advocacy. The group meets quarterly to better understand patient and family needs while improving the culture within the hyperoxaluria community. The PAB works along side OHF staff expanding outreach and raising awareness in local communities across the United States.

If you would like to make an impact, please contact Julie Bertarelli at julieb@ohf.org or 1-800-OHF-8699 x2.





The OHF is a 501 (c)(3), public charity.
© Oxalosis & Hyperoxaluria Foundation (OHF) · Legal Disclaimer

For problems with this website please email webmaster@ohf.org

Website design ©1996 - 2011 Relevant Arts
 

Donate Now!